Sage Journals: Discover world-class research

Open access

Review article

First published 2019

A review of sotagliflozin for use in type 1 diabetes

Wesley Nuffer, Briana Williams, Jennifer M. Trujillo

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Review article

First published 2024-9

Sotagliflozin: Efficacy,Safety,and Potential Therapeutic Applications in Heart Failure

Allissa Long, Marissa Salvo

Annals of Pharmacotherapy

Free access

Research article

First published 2015-3

Development of sotagliflozin,a dual sodium-dependent glucose transporter 1/2 inhibitor

Pablo Lapuerta, Brian Zambrowicz, Paul Strumph [...]

Diabetes & Vascular Disease Research

Open access

Brief report

First published 2021-1

Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2

Helena W Rodbard, Andrea Giaccari, Bertrand Cariou [...]

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2021-01

Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study

Bruce W. Bode, Eda Cengiz, R. Paul Wadwa [...]

Diabetes Technology & Therapeutics

Retricted access

Review article

First published 2024-10

A Review of the Potential Role of Sotagliflozin: A Dual SGLT2 and SGLT1 Inhibitor—in the Treatment of Heart Failure

Bao Anh C. Tran, Raechel T. White, Krystal Bullers [...]

Journal of Pharmacy Technology

Open access

Research article

First published 2024-09

Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin

Schafer Boeder, Michael J. Davies, Janet B. McGill [...]

Diabetes Technology & Therapeutics

Open access

Research article

First published 2021-01

Improvement in Patient-Reported Outcomes in Adults with Type 1 Diabetes Treated with Sotagliflozin plus Insulin Versus Insulin Alone

Thomas Danne, Vijay N. Joish, Marion Afonso [...]

Diabetes Technology & Therapeutics

Open access

Research article

First published 2019-09

Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes

Thomas Danne, Jeremy Pettus, Andrea Giaccari [...]

Diabetes Technology & Therapeutics

Retricted access

Review article

First published 2019-12

Sodium-Glucose Cotransporters as Potential Therapeutic Targets in Patients With Type 1 Diabetes Mellitus: An Update on Phase 3 Clinical Trial Data

Kajal Patel, Antonia Carbone

Annals of Pharmacotherapy

Search results